| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-17 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-11 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.3 | 5e-09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |